CSN Login
Members Online: 13

You are here

Trial: anti-PD1 and anti-KIR combined

Alexandra's picture
Alexandra
Posts: 1311
Joined: Jul 2012

IS ANYONE PARTICIPATING IN THIS TRIAL?

This trial sounds very promising. It combines two experimental drugs, the much-sought-after PD-1 drug BMS-936558 (nivolumab) and an anti-KIR drug BMS-986015. This trial is available to qualified patients with colorectal cancer, kidney cancer, melanoma, NSCLC (non-small cell lung cancer), and ovarian cancer. The trial is underway in Baltimore, Chicago, and New York.

Note: This trial is not yet recruiting in Boston or Portland.

http://clinicaltrials.gov/show/NCT01714739

 

DaveMcF
Posts: 1
Joined: Jun 2014

Curious if anyone has particiapted in this trial.  I am just starting my search for a promising trial that includes Anti-PD1.

Subscribe to Comments for "Trial: anti-PD1 and anti-KIR combined"